Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard   

Previous Fragment    Next Fragment
Friday, 29 May 1987
Page: 3662

(Question No. 5266)

Mr Hodges asked the Minister for Health, upon notice, on 1 April 1987:

(1) Did his Department conduct an internal inquiry into the method by which approvals were granted for the listing of 40 generic drugs on the Pharmaceutical Benefits List; if so, (a) when was the inquiry completed and (b) were the roles played by Australian Drug Evaluation Committee, the Pharmaceutical Benefits Advisory Committee and the Therapeutic Goods Section of his Department considered during the inquiry.

(2) Were the actions of any other bodies or individuals taken into account during the inquiry; if so, which bodies or individuals were taken into account.

(3) Will he provide me with a copy of the inquiry's report or table it in Parliament.

Dr Blewett —The answer to the honourable member's question is as follows:

(1) and (2) An investigation was carried out early this year into problems within the Therapeutics Division of the Department. In consultation with my officers in the course of that investigation it was decided that we would set up an independent inquiry, which is now under way, supported by an expert brought in from overseas to make a fully impartial study of the problems in the Therapeutics Division.

(3) I intend tabling the report of the independent review in due course.